Home Contact Shopping Video

CB1 Receptor Silencing Attenuates Ketamine-Induced Hyperlocomotion Without Compromising Its Antidepressant-Like Effects

September 7th, 2022 | Posted in Cannabinoid Research | Comments Off on CB1 Receptor Silencing Attenuates Ketamine-Induced Hyperlocomotion Without Compromising Its Antidepressant-Like Effects

CB1 Receptor Silencing Attenuates Ketamine-Induced Hyperlocomotion Without Compromising Its Antidepressant-Like Effects

Cannabis and Cannabinoid Research, Ahead of Print.

Go to Source

Powered by WPeMatico

RSS Subscribe


Related Posts